128 related articles for article (PubMed ID: 2900740)
1. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
Maiorino RM; Weber GL; Aposhian HV
Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
[TBL] [Abstract][Full Text] [Related]
2. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
Maiorino RM; Xu ZF; Aposhian HV
J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
[TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
Maiorino RM; Dart RC; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628
[TBL] [Abstract][Full Text] [Related]
4. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
Stewart JR; Diamond GL
Drug Metab Dispos; 1988; 16(2):189-95. PubMed ID: 2898331
[TBL] [Abstract][Full Text] [Related]
5. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiols in urine.
Maiorino RM; Barry TJ; Aposhian HV
Anal Biochem; 1987 Jan; 160(1):217-26. PubMed ID: 3032019
[TBL] [Abstract][Full Text] [Related]
6. Fluorometric determination of 2,3-dimercaptopropane-1-sulfonic acid and other dithiols by precolumn derivatization with bromobimane and column liquid chromatography.
Maiorino RM; Weber GL; Aposhian HV
J Chromatogr; 1986 Jan; 374(2):297-310. PubMed ID: 3958088
[TBL] [Abstract][Full Text] [Related]
7. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
Diamond GL; Klotzbach JM; Stewart JR
J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
[TBL] [Abstract][Full Text] [Related]
8. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.
Hurlbut KM; Maiorino RM; Mayersohn M; Dart RC; Bruce DC; Aposhian HV
J Pharmacol Exp Ther; 1994 Feb; 268(2):662-8. PubMed ID: 8113976
[TBL] [Abstract][Full Text] [Related]
9. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate.
Gabard B; Walser R
J Toxicol Environ Health; 1979 Jul; 5(4):759-64. PubMed ID: 490684
[TBL] [Abstract][Full Text] [Related]
10. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
Maiorino RM; Bruce DC; Aposhian HV
Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
[TBL] [Abstract][Full Text] [Related]
11. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam.
Høl PJ; Vamnes JS; Gjerdet NR; Eide R; Isrenn R
Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026
[TBL] [Abstract][Full Text] [Related]
12. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
Maiorino RM; Aposhian HV
Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
[TBL] [Abstract][Full Text] [Related]
13. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
[TBL] [Abstract][Full Text] [Related]
14. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
[TBL] [Abstract][Full Text] [Related]
15. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
Nogueira CW; Santos FW; Soares FA; Rocha JB
Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
[TBL] [Abstract][Full Text] [Related]
16. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
Chisolm JJ; Thomas DJ
J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728
[TBL] [Abstract][Full Text] [Related]
17. The role of thiol-reducing agents on modulation of glutamate binding induced by heavy metals in platelets.
Borges VC; Nogueira CW
Toxicol In Vitro; 2008 Mar; 22(2):438-43. PubMed ID: 18068946
[TBL] [Abstract][Full Text] [Related]
18. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
[TBL] [Abstract][Full Text] [Related]
19. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
[TBL] [Abstract][Full Text] [Related]
20. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
